Natalie Loundon

Natalie Loundon

Auto-generated profile, based on publicly available information

Natalie Loundon

Service d’ORL et de Chirurgie Cervico-Faciale, Hôpital d’Enfants Armand-Trousseau, AP-HP, Paris, France

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2010 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
NLNatalie Loundon
Natalie Loundon
MBMarion Blanchard
Marion Blanchard
GRGilles Roger
Gilles Roger
FDFrançoise Denoyelle
Françoise Denoyelle
EGErea Noël Garabedian
Erea Noël Garabedian
The success of cochlear implantation (CI) as an auditory rehabilitative tool requires a thorough knowledge of indications, limitations, and potential risks. Since 1990, the number of pediatric CIs has increased significantly, and more specific pediatric evaluation of the medical and surgical risks can be collected. This study reports on the complications occurring in a pediatric population and analyzes the predisposing risk factors.

1 June 2005 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
SMSandrine Marlin
Sandrine Marlin
DFDelphine Feldmann
Delphine Feldmann
HBHélène Blons
Hélène Blons
NLNatalie Loundon
Natalie Loundon
IRIsabelle Rouillon
Isabelle Rouillon
FDFrançoise Denoyelle
Françoise Denoyelle
Hearing loss is the most frequent sensory deficit. One child in 1000 is born with severe or profound deafness, and another 1 in 1000 becomes deaf before adulthood. Recent work in human genetics indicates that 60% to 80% of cases of congenital deafness are of genetic origin in developed countries1 and that nonsyndromic sensorineural hearing loss (NSSNHL) is mainly autosomal recessive. Since 1994, more than 80 loci for NSSNHL have been identified, and 35 different genes have been cloned.1 Despite extensive genetic heterogeneity, a single locus on chromosome band 13q12 has been recognized to account for a large proportion of cases of nonsyndromic autosomal recessive deafness (DFNB1). Furthermore, the gene that encodes connexin 26, GJB2, has been identified as causative in DFNB1.1 The GJB2 gene is also involved in an autosomal dominant form of deafness, DFNA3, and in syndromes such as Vohwinkel or keratitis-ichtyosis-deafness syndrome. The GJB6 gene, which encodes connexin 30, maps close to GJB2. The GJB6 gene was first described as causative in a rare dominant form of deafness, DFNA3, and its implication in NSSNHL was ascertained through the identification of a large deletion that includes the GJB6 5′-end noncoding region and most of the coding region. This genetic alteration was found in patients with hearing impairment who carry a GJB2 mutation in trans and at a homozygous state in some families.2-4 In those patients, it is still not clear whether the deafness is due to a digenic pattern of inheritance or whether the deletion removes common GJB6 and GJB2 regulatory elements.5

1 February 2013 in Otology & Neurotology
Verified
Journal Article
Closed access
FDFrançoise Denoyelle
Françoise Denoyelle
NLNicolas Leboulanger
Nicolas Leboulanger
CCCyrille Coudert
Cyrille Coudert
OMOlivia Mazzaschi
Olivia Mazzaschi
NLNatalie Loundon
Natalie Loundon
EGEréa-Noël Garabedian
Eréa-Noël Garabedian
Objective To report preliminary results of a new closed-skin, transcutaneous bone conduction device (BCD) in 6 children with high-grade ear atresia Settings Tertiary care center; prospective study; we evaluated the gain with masking of the contralateral ear and the benefit of hearing rehabilitation with the transcutaneous BCD in noise: speech-in-noise tests, conducted in real life condition (with contralateral ear unmasked and fitted with a hearing device if done before implantation), with and without BCD, with determination of the speech reception threshold (SRT). Children and parent’s satisfaction was assessed. Results Patients’ ages ranged from 6 to 9 years. All had high-grade ear atresia with a preoperative mean pure-tone average (PTA) loss of 71.46 ± 6.59 dB on air conduction and 14 ± 4.98 dB on bone conduction. At M6, all children used the implant 5 to 12 hours daily (mean, 10) without pain or cutaneous complications. At M6, the mean air conduction PTA with transcutaneous BCD was 28.45 ± 1.68 dB, the mean gain 43 ± 6.96 dB, and the mean SRT gain 33.33 ± 10.75 dB. Using speech-in-noise tests in real-life conditions, the mean SRT was statistically improved with the transcutaneous BCD (−8 ± 2.83 dB, p = 0.0313). Both children and parents reported being satisfied or very satisfied. Conclusion These preliminary results show satisfactory functional gain, cutaneous tolerance, and patients’ satisfaction with the new transcutaneous BCD.

14 February 2013
Verified
Journal Article
Closed access
PDF file
IMIsabelle Mosnier
Isabelle Mosnier
MMMathieu Marx
Mathieu Marx
FVFrederic Venail
Frederic Venail
NLNatalie Loundon
Natalie Loundon
SRSamantha Roux-Vaillard
Samantha Roux-Vaillard
Olivier SterkersOlivier Sterkers
Olivier Sterkers

1 October 2013 in Otology & Neurotology
Verified
Journal Article
Closed access
DPDaniel Philippon
Daniel Philippon
NLNathalie Laflamme
Nathalie Laflamme
NLNicolas Leboulanger
Nicolas Leboulanger
NLNatalie Loundon
Natalie Loundon
IRIsabelle Rouillon
Isabelle Rouillon
FDFrancoise Denoyelle
Francoise Denoyelle
To standardize the information for families of children having functional surgery for middle ear malformations, we describe the audiometric results of the subgroup of patients with the most favorable anatomic conditions: viable auditory canal, intact tympanic membrane, mobile stapes, and corresponding to a Jahrsdoerfer score of 8 or higher. Case series, tertiary referral center. Charts of patients undergoing functional surgery for congenital middle ear malformations were reviewed for demographic data, preoperative Jahrsdoerfer score, ossicular chain status, type of ossiculoplasty, and audiometric data before and 6 months postsurgery. Eighteen consecutive interventions were performed on 13 patients (average age of 9 years, 8 girls and 5 boys) between 2004 and 2011. The ossiculoplasties performed were as follows: incus repositioning (4), double-layer tragal cartilage (5), intact native chain reconstruction (3), and partial ossicular prosthesis (6). Mean air bone gap (ABG) was 40.8 ± 12.4 dB preoperatively and 20.9 ± 12.9 dB postoperatively (p < 0.0001). Preoperative and postoperatively mean air conduction PTA thresholds were 49.9 ± 9.5 and 30.0 ± 14.1 dB, respectively (p < 0.0001). All ears operated on except one had air conduction improvement. There were no complications. Functional surgery for congenital middle ear malformations gives variable hearing outcomes. In this study, with the most favorable anatomic conditions, 12 ears (67%) of 18 had air conduction improvement below 30 dB.

1 June 2012 in Otology & Neurotology
Verified
Journal Article
Closed access
WBWissame El Bakkouri
Wissame El Bakkouri
NLNatalie Loundon
Natalie Loundon
BTBriac Thierry
Briac Thierry
JNJerome Nevoux
Jerome Nevoux
SMSandrine Marlin
Sandrine Marlin
EGErea Noel Garabédian
Erea Noel Garabédian
Objective: To evaluate the perceptive and linguistic results in 2 predefined genetic population of children with implants. Study Design: Retrospective cohort study. Setting: Otolaryngology department of a tertiary referral hospital. Patients Among 336 children with prelingual deafness who underwent implantation in our department between 1997 and 2007, 85 with GJB2 gene-related (Cx) deafness and 30 patients with Waardenburg syndrome (WaardS) were included. Mean age at implantation was 4.7 years (range, 15 mo to 16.5 yr) in the Cx group and 4.8 years (range, 16 mo to 16 yr) in the WaardS group. The mean follow-up period was 6.5 years (range, 19 mo to 12 yr) in the Cx group and 7.1 years (range, 27 mo to 13.5 yr) in the WaardS group. More than 75% of the families in both groups scored 4 and 5 when using the Mary Pat Moeller rating (p > 0.05). A psychoneurological evaluation was performed in one third of the patients in both groups. Main Outcome Measures Patients underwent linguistic and perceptive evaluations at 12, 24, 36, and 48 months: speech perception with closed-set and open-set words, speech production (Level 1 = vocalizations to Level 5 = complex sentences), and lexical comprehension with EVIP/GaelP (Peabody Picture Vocabulary Test) tests that ranged in 5 levels (−2 SD to +2 SD). Results Score results for open-set words were 38.5%, 57.5%, 69%, and 75% in the Cx group and 30.5%, 59%, 67.5%, and 78% in the WaardS group (p > 0.05) at 12, 24, 36, and 48 months. The proportion of children in Levels 4 and 5 of speech production was 27%, 42%, 57.5%, and 58% in the Cx group and 23%, 33%, 55%, and 66% in the WaardS group (p > 0.05). Lexical result at Level −2 SD at 1 year was 90% in the Cx group and 85% in the WaardS group and that at 4 years was 70% in the Cx group and 65% in the WaardS group (p > 0.05). Conclusion Perceptive and linguistic evolutions for both populations were of good quality, but lexical evaluation showed residual language difficulties in both groups.